StonvexLoading…
StonvexStonvexStonvexCore line items from SLND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $172.41M | $772.17M | $668.21M | $454.87M |
Operating Income | $-19.70M | $-216.88M | $-6.51M | $4.81M |
Net Income | $-28.35M | $-306.54M | $-90.13M | $-14.86M |
EPS (Diluted) | $-0.52 | $-5.67 | $-1.67 | $-0.28 |
Total Assets | $928.08M | $989.28M | $1.14B | $1.19B |
Total Liabilities | $1.09B | $1.12B | $1.05B | $1.02B |
Cash & Equivalents | $20.54M | $52.71M | $40.48M | $46.52M |
Free Cash Flow OCF − CapEx | $-133.89M | $12.73M | $3.45M | $-1.89M |
Shares Outstanding | 54.20M | 54.11M | 54.11M | 54.11M |